SLXNW — SILEXION THERAPEUTICS CORP
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 19 SEC-registered investment managers reported holding SLXNW (SILEXION THERAPEUTICS CORP) in their latest 13F filings, with a combined reported value of $328.40K across 2.31M shares. That is -1.1% by share count (-24.47K shares) versus the previous quarter, while reported value moved -70.6%. Ownership is concentrated: the five largest holders account for 97.8% of reported value and the top ten for 99.4%.
Compared with the prior quarter, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of SILEXION THERAPEUTICS CORP (SLXNW) include DUPONT CAPITAL MANAGEMENT CORP, Hartree Partners, LP, PERISCOPE CAPITAL INC., ranked by reported 13F value among the 37 institutional holders on this page.
SLXNW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 19 | 2.31M | $328.40K | -1.1% |
| Q2 2026 | 22 | 2.46M | $1.12M | +0.0% |
| Q1 2026 | 22 | 2.38M | $80.63K | +0.1% |
| Q4 2025 | 24 | 2.39M | $111.00K | +0.2% |
| Q3 2025 | 25 | 2.78M | $183.58K | +2.9% |
| Q2 2025 | 23 | 2.47M | $271.60K | +4.3% |
| Q1 2025 | 27 | 2.62M | $7.94M | -0.4% |
| Q4 2024 | 27 | 2.52M | $6.49M | +0.0% |
Over the 8 quarters shown, institutional share counts decreased 8% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+4.3%).
Top Institutional Holders (Q3 2026) — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 32.50K | $306.00K | 0.02% | Hold | |
| 743.48K | $5.65K | 0.00% | Hold | |
| 14.18K | $3.97K | 0.00% | Hold | |
| 11.11K | $3.08K | 0.00% | Hold | |
| 337.50K | $2.56K | 0.00% | Hold | |
| 214.85K | $1.63K | 0.00% | Reduce | |
| 150.00K | $1.41K | 0.00% | Hold | |
| 217.47K | $1.11K | 0.00% | Hold | |
| 123.03K | $627 | 0.00% | Reduce | |
| 100.00K | $510 | 0.00% | Hold | |
| 74.91K | $382 | 0.00% | Hold | |
| 57.17K | $292 | 0.00% | Hold | |
| 51.18K | $261 | 0.00% | Hold | |
| 50.00K | $255 | 0.00% | Hold | |
| 38.15K | $195 | 0.00% | Hold | |
| 31.55K | $161 | 0.00% | Hold | |
| 30.50K | $156 | 0.00% | Hold | |
| 16.00K | $82 | 0.00% | Hold | |
| 12.50K | $64 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 22 funds
Q1 2026 — 22 funds
Q4 2025 — 24 funds
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.18K | $48.22K | 0.00% | Hold | |
| 11.11K | $37.78K | 0.01% | New | |
| 743.48K | $26.17K | 0.00% | Hold | |
| 337.50K | $12.18K | 0.00% | Hold | |
| 236.55K | $8.34K | 0.00% | Hold | |
| 220.05K | $7.75K | 0.00% | Add | |
| 219.56K | $7.73K | 0.00% | New | |
| 182.35K | $7.29K | 0.00% | Hold | |
| 150.00K | $5.28K | 0.00% | Hold | |
| 116.64K | $4.11K | 0.00% | Add | |
| 100.00K | $4.00K | 0.02% | Hold | |
| 74.91K | $2.64K | 0.00% | Hold | |
| 51.18K | $1.80K | 0.00% | Hold | |
| 50.00K | $1.76K | 0.00% | Hold | |
| 38.15K | $1.34K | 0.00% | Hold | |
| 32.50K | $1.14K | 0.00% | Hold | |
| 31.55K | $1.11K | 0.00% | Hold | |
| 30.50K | $1.07K | 0.00% | Hold | |
| 25.00K | $1.00K | 0.00% | Hold | |
| 57.17K | $1.00K | 0.00% | Hold | |
| 16.00K | $563 | 0.00% | Hold | |
| 12.50K | $440 | 0.00% | Hold | |
| 12.50K | $440 | 0.00% | Hold | |
| 11.94K | $421 | 0.00% | Hold | |
| 100 | $4 | 0.00% | Hold |
Q2 2025 — 23 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.18K | $172.32K | 0.01% | Hold | |
| 743.48K | $30.41K | 0.00% | Hold | |
| 337.50K | $13.97K | 0.00% | Hold | |
| 236.55K | $9.78K | 0.00% | Hold | |
| 182.35K | $7.29K | 0.00% | Hold | |
| 150.98K | $5.75K | 0.00% | Add | |
| 150.00K | $5.71K | 0.00% | Hold | |
| 113.57K | $4.64K | 0.00% | Add | |
| 100.00K | $4.00K | 0.01% | Hold | |
| 74.91K | $3.06K | 0.00% | Reduce | |
| 51.18K | $2.09K | 0.00% | Hold | |
| 50.00K | $2.04K | 0.00% | Hold | |
| 57.17K | $2.00K | 0.00% | Hold | |
| 38.15K | $1.56K | 0.00% | Hold | |
| 31.55K | $1.29K | 0.00% | Hold | |
| 30.50K | $1.25K | 0.00% | Hold | |
| 32.50K | $1.24K | 0.00% | Hold | |
| 25.00K | $1.00K | 0.00% | Hold | |
| 16.00K | $654 | 0.00% | Hold | |
| 12.50K | $511 | 0.00% | Hold | |
| 12.50K | $511 | 0.00% | Hold | |
| 11.94K | $488 | 0.00% | Hold | |
| 100 | $4 | 0.00% | Reduce |
New Positions (Q3 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 92.07K sh · $2.80K
- Mint Tower Capital Management B.V. sold 25.00K sh · $1.00K
- Millennium Management sold 12.50K sh · $380
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| DUPONT CAPITAL MANAGEMENT CORP | 32.50K | 32.50K | 32.50K | 32.50K | 32.50K | 32.50K | 32.50K | 32.50K | 32.50K |
| Polar Asset Management Partners Inc. | 743.48K | 743.48K | 743.48K | 743.48K | 743.48K | 743.48K | 743.48K | 743.48K | 743.48K |
| DeepCurrents Investment Group LLC | 14.18K | 14.18K | 14.18K | 14.18K | 14.18K | 14.18K | 14.18K | 14.18K | 14.18K |
| Oasis Management Co Ltd. | 11.11K | 11.11K | 11.11K | 11.11K | 11.11K | — | — | — | — |
| LINDEN ADVISORS LP | 337.50K | 337.50K | 337.50K | 337.50K | 337.50K | 337.50K | 337.50K | 337.50K | 337.50K |
| ARISTEIA CAPITAL, L.L.C. | 214.85K | 236.55K | 236.55K | 236.55K | 236.55K | 236.55K | 236.55K | 242.17K | 242.17K |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
| Clear Street Group Inc. | 217.47K | 218.16K | 218.76K | 218.97K | 219.56K | — | — | — | — |
| Goldman Sachs Group | 123.03K | 125.10K | 123.49K | 121.24K | 116.64K | 113.57K | 110.09K | 107.47K | 93.29K |
| Kepos Capital LP | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| JANE STREET GROUP, LLC | 74.91K | 74.91K | 74.91K | 74.91K | 74.91K | 74.91K | 75.30K | 75.72K | 75.72K |
| PICTON MAHONEY ASSET MANAGEMENT | 57.17K | 57.17K | 57.17K | 57.17K | 57.17K | 57.17K | 57.17K | 57.17K | 57.17K |
| Context Capital Management, LLC | 51.18K | 51.18K | 51.18K | 51.18K | 51.18K | 51.18K | 51.18K | 51.18K | 62.24K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 38.15K | 38.15K | 38.15K | 38.15K | 38.15K | 38.15K | 38.15K | — | 38.15K |
| Neuberger Berman Group LLC | 31.55K | 31.55K | 31.55K | 31.55K | 31.55K | 31.55K | 31.55K | 31.55K | 31.55K |
| GABELLI FUNDS LLC | 30.50K | 30.50K | 30.50K | 30.50K | 30.50K | 30.50K | 30.50K | — | 30.50K |
| STIFEL FINANCIAL CORP | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K | 16.00K |
| MILLENNIUM MANAGEMENT LLC | 12.50K | 12.50K | 12.50K | 12.50K | 12.50K | 12.50K | 12.50K | 12.50K | 12.50K |
| PERISCOPE CAPITAL INC. | — | — | — | — | — | — | 87.17K | 87.17K | 104.54K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SLXNW?
As of 2026-Q3, 19 institutional funds reported holding SLXNW (SILEXION THERAPEUTICS CORP) in SEC 13F filings, with a combined reported value of $328.40K.
How many shares of SLXNW do institutions own?
13F filers reported 2.31M shares of SLXNW, worth $328.40K in aggregate at the end of 2026-Q3.
Is institutional ownership of SLXNW rising or falling?
Share counts moved -1.1% versus the prior quarter — distribution.
Who are the top institutional holders of SLXNW?
The largest 13F holders are DUPONT CAPITAL MANAGEMENT CORP, Hartree Partners, LP, PERISCOPE CAPITAL INC., Tabor Asset Management, LP, Yakira Capital Management, Inc.; the top 25 are ranked at the top of this page.
Who are the major shareholders of SILEXION THERAPEUTICS CORP?
The major shareholders of SILEXION THERAPEUTICS CORP (SLXNW) by reported 13F value are DUPONT CAPITAL MANAGEMENT CORP, Hartree Partners, LP, PERISCOPE CAPITAL INC., Tabor Asset Management, LP, Yakira Capital Management, Inc., among 37 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.